Clarke to Give Sigma Xi Distinguished Lecture on Breast Cancer Research

Posted on 3/16/2015 12:54:58 PM

Robert Clarke will present the Sigma Xi Distinguished Lecture on Thursday, April 9, 2015, at 7:30 p.m. in Eberly Auditorium. The title of his presentation is “What can we learn about breast cancer by combining mathematics and computer science in a systems biology approach to research?”

Clarke studies how hormones and growth factors affect breast cancer.

Focusing initially on the interactions among hormones and anticancer drugs, his work expanded to include the cellular and molecular mechanisms that explain how breast cancers become resistant to hormone and cytotoxic drug chemotherapies. Clarke has authored/co-authored over 225 publications and he has several patents, mostly in the field of breast cancer research.

Robert Clarke is a professor of oncology at Georgetown University Medical Center and an elected Fellow of the Royal Society of Chemistry, the Royal Society of Medicine, and the Royal Society of Biology (U.K.).

A native of Northern Ireland, he earned a DSc in 1999, a PhD in 1986, and an MSc in 1982 (each in Biochemistry) from the Queen's University of Belfast, and a BSc (Biological Sciences) in 1980 from the University of Ulster. Clarke completed his postdoctoral training in 1988 as a Breast Cancer Study Group Fellow at the Medical Breast Section of the National Cancer Institute, N.I.H. He joined the faculty at Georgetown University in 1989, where he served as secretary/treasurer of the Georgetown University Faculty Senate (2004–07). He serves on the editorial board of over a dozen peer review journals and chaired the N.I.H. Basic Mechanisms of Cancer Therapeutics grant review panel (2011–13).

The lecture is free and open to the public.

College of Natural Sciences and Mathematics